Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF) (2016 - 2026)
Cumberland Pharmaceuticals' Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $1.0 million for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 30.37% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.1 million, a 15.45% decrease, with the full-year FY2025 number at $4.1 million, down 15.45% from a year prior.
- Depreciation & Amortization (CF) hit $1.0 million in Q4 2025 for Cumberland Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for CPIX hit a ceiling of $1.7 million in Q1 2022 and a floor of $511483.0 in Q4 2022.
- Historically, Depreciation & Amortization (CF) has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
- Biggest five-year swings in Depreciation & Amortization (CF): crashed 52.51% in 2022 and later surged 141.12% in 2023.
- Tracing CPIX's Depreciation & Amortization (CF) over 5 years: stood at $1.1 million in 2021, then crashed by 52.51% to $511483.0 in 2022, then surged by 141.12% to $1.2 million in 2023, then grew by 21.34% to $1.5 million in 2024, then plummeted by 30.37% to $1.0 million in 2025.
- Business Quant data shows Depreciation & Amortization (CF) for CPIX at $1.0 million in Q4 2025, $1.0 million in Q3 2025, and $1.0 million in Q2 2025.